Clinical Trial Update: Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports on the immunogenicity and safety of a combined measles, mumps, rubella, and varicella vaccine developed by GlaxoSmithKline; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• Priorix-TVR (Measles, Mumps, Rubella, Varicella vaccine (live, attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Mumps, Rubella | Phase 4 | Status: COMPLETED